PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer

Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging

(2013) N. Schleich et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Biological applications of magnetic nanoparticles

(2012) Miriam Colombo et al.   CHEMICAL SOCIETY REVIEWS

Synthesis andin vitroevaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer

(2012) Mohammad Abdolahi et al.   Contrast Media & Molecular Imaging

Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma

(2012) Lihong Bu et al.   Contrast Media & Molecular Imaging

Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy

(2012) Xin Gao et al.   International Journal of Nanomedicine

Magnetic Nanoparticles for Cancer Diagnosis and Therapy

(2012) Mehmet V. Yigit et al.   PHARMACEUTICAL RESEARCH

Applications and Potential Toxicity of Magnetic Iron Oxide Nanoparticles

(2012) Gang Liu et al.   Small

Prostate-specific membrane antigen-based imaging

(2012) Joseph R. Osborne et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The journey of a drug-carrier in the body: An anatomo-physiological perspective

(2011) Nicolas Bertrand et al.   JOURNAL OF CONTROLLED RELEASE

Engineered nanoparticles for biomolecular imaging

(2011) Morteza Mahmoudi et al.   Nanoscale

MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model

(2011) Mingqian Tan et al.   PHARMACEUTICAL RESEARCH

Challenges in Clinical Prostate Cancer: Role of Imaging

(2009) Gary J. Kelloff et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells

(2008) Benjamin Thierry et al.   ADVANCED MATERIALS

Nanoparticle-enhanced MRI: are we there yet?

(2008) Mukesh Harisinghani   LANCET ONCOLOGY